{"id":"https://openalex.org/W4361952227","doi":"https://doi.org/10.1158/1078-0432.c.6523238","title":"Data from LOH in the HLA Class I Region at 6p21 Is Associated with Shorter Survival in Newly Diagnosed Adult Glioblastoma","display_name":"Data from LOH in the HLA Class I Region at 6p21 Is Associated with Shorter Survival in Newly Diagnosed Adult Glioblastoma","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361952227","doi":"https://doi.org/10.1158/1078-0432.c.6523238"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6523238","doi":"https://doi.org/10.1158/1078-0432.c.6523238","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6523238","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.c.6523238","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033298364","display_name":"Jacky T. Yeung","orcid":"https://orcid.org/0000-0001-7336-5738","observed_orcids":["https://orcid.org/0000-0001-7336-5738"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jacky T. Yeung","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002782232","display_name":"Ronald L. Hamilton","orcid":"https://orcid.org/0000-0002-6802-1102","observed_orcids":["https://orcid.org/0000-0002-6802-1102"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ronald L. Hamilton","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034461650","display_name":"Koji Ohnishi","orcid":"https://orcid.org/0000-0002-6790-6902","observed_orcids":["https://orcid.org/0000-0002-6790-6902"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Koji Ohnishi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042121198","display_name":"Maki Ikeura","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maki Ikeura","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111991039","display_name":"Douglas M. Potter","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Douglas M. Potter","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036048186","display_name":"Marina N. Nikiforova","orcid":"https://orcid.org/0000-0001-9976-9378","observed_orcids":["https://orcid.org/0000-0001-9976-9378"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marina N. Nikiforova","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028669896","display_name":"Soldano Ferrone","orcid":"https://orcid.org/0000-0003-2900-8834","observed_orcids":["https://orcid.org/0000-0003-2900-8834"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Soldano Ferrone","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109204083","display_name":"Regina I. Jakacki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Regina I. Jakacki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080784534","display_name":"Ian F. Pollack","orcid":"https://orcid.org/0000-0003-1765-357X","observed_orcids":["https://orcid.org/0000-0003-1765-357X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ian F. Pollack","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5058793243","display_name":"Hideho Okada","orcid":"https://orcid.org/0000-0003-0076-9920","observed_orcids":["https://orcid.org/0000-0003-0076-9920"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hideho Okada","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9750999808311462,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9750999808311462,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.02250000089406967,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/loss-of-heterozygosity","display_name":"loss of heterozygosity","score":0.9959999918937683},{"id":"https://openalex.org/keywords/hla-class-i","display_name":"HLA class I","score":0.9739999771118164},{"id":"https://openalex.org/keywords/6p21","display_name":"6p21","score":0.9539999961853027},{"id":"https://openalex.org/keywords/beta2-microglobulin","display_name":"beta2-microglobulin","score":0.9129999876022339},{"id":"https://openalex.org/keywords/hla-class-ii","display_name":"HLA class II","score":0.8349999785423279},{"id":"https://openalex.org/keywords/hla-class-iii","display_name":"HLA class III","score":0.968999981880188},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6629999876022339},{"id":"https://openalex.org/keywords/hla-downregulation","display_name":"HLA downregulation","score":0.8040000200271606},{"id":"https://openalex.org/keywords/cd8-t-cell-infiltration","display_name":"CD8+ T cell infiltration","score":0.9430000185966492},{"id":"https://openalex.org/keywords/tumor-surveillance","display_name":"tumor surveillance","score":0.9190000295639038},{"id":"https://openalex.org/keywords/microsatellite-analysis","display_name":"microsatellite analysis","score":0.640999972820282},{"id":"https://openalex.org/keywords/immunotherapy-resistance","display_name":"immunotherapy resistance","score":0.6019999980926514}],"concepts":[{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.682218611240387},{"id":"https://openalex.org/C188280979","wikidata":"https://www.wikidata.org/wiki/Q911125","display_name":"Human leukocyte antigen","level":3,"score":0.6152194738388062},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.564693808555603},{"id":"https://openalex.org/C143589142","wikidata":"https://www.wikidata.org/wiki/Q2617554","display_name":"Loss of heterozygosity","level":4,"score":0.49429941177368164},{"id":"https://openalex.org/C21957315","wikidata":"https://www.wikidata.org/wiki/Q287896","display_name":"Beta-2 microglobulin","level":2,"score":0.47250282764434814},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.45381540060043335},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.39686480164527893},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.3522694706916809},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3331512212753296},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.31475937366485596},{"id":"https://openalex.org/C180754005","wikidata":"https://www.wikidata.org/wiki/Q80726","display_name":"Allele","level":3,"score":0.17094722390174866},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.168107807636261},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.08784964680671692}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.c.6523238","doi":"https://doi.org/10.1158/1078-0432.c.6523238","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6523238","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.c.6523238.v1","doi":"https://doi.org/10.1158/1078-0432.c.6523238.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6523238.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6523238","doi":"https://doi.org/10.1158/1078-0432.c.6523238","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6523238","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2152043562","https://openalex.org/W4213037439","https://openalex.org/W2171146653","https://openalex.org/W1568276869","https://openalex.org/W3169516567","https://openalex.org/W2330143046","https://openalex.org/W2312288366","https://openalex.org/W1835502420","https://openalex.org/W160271021","https://openalex.org/W4392815743"],"abstract_inverted_index":{"Abstract":[0],"Purpose:":[1],"Glioblastoma":[2],"(GBM)":[3],"shows":[4],"downregulated":[5,165],"expression":[6,110,186],"of":[7,24,27,30,51,86,106,140,145,170,208],"human":[8],"leukocyte":[9],"antigen":[10],"(HLA)":[11],"class":[12,32,88,92,95,108,119,123,126,147,162,184,198],"I,":[13,89,120],"thereby":[14],"escaping":[15],"from":[16,76],"cytotoxic":[17],"T":[18],"cells":[19],"and":[20,55,97,111,128,138],"limiting":[21],"the":[22,49,196],"efficacy":[23],"immunotherapy.":[25],"Loss":[26],"heterozygosity":[28],"(LOH)":[29],"HLA":[31,87,91,94,107,118,122,125,146,161,183,197],"I":[33,109,148,163,185,199],"(6p21)":[34],"and/or":[35],"\u03b2-2":[36],"microglobulin":[37],"(B2m)":[38],"(15q21)":[39],"regions":[40,85,130],"represents":[41],"irreversible":[42],"downregulation.":[43],"In":[44,65],"this":[45,214],"study,":[46],"we":[47],"examined":[48],"prevalence":[50],"these":[52,221],"LOH":[53,116,144,194,212],"events":[54],"their":[56],"relations":[57],"with":[58,73,151,188,211],"overall":[59,153],"survival":[60,154,210],"in":[61,117,133,166,195,203,213,223],"GBM.":[62],"Experimental":[63],"Design:":[64],"a":[66,217],"cross-sectional":[67],"analysis":[68],"on":[69,173],"60":[70],"adult":[71,204],"patients":[72],"GBM,":[74],"DNA":[75],"formalin-fixed,":[77],"paraffin-embedded":[78],"specimens":[79],"were":[80,180],"evaluated":[81],"for":[82,220],"10":[83],"microsatellite":[84],"B2m,":[90,121],"II,":[93,124],"III,":[96,127],"6q":[98,129],"by":[99],"PCR":[100],"as":[101,103],"well":[102],"immunohistochemical":[104],"evaluation":[105],"CD8+":[112,190],"T-cell":[113,191],"infiltration.":[114,192],"Results:":[115],"was":[131,149,164],"present":[132],"41.4%,":[134],"18.2%,":[135],"9.4%,":[136],"77.8%,":[137],"36.0%":[139],"informative":[141],"cases,":[142],"respectively.":[143],"associated":[150],"shorter":[152,209],"(HR":[155],"=":[156,159],"4.89,":[157],"P":[158],"0.0078).":[160],"22%":[167],"to":[168],"43%":[169],"cases":[171],"based":[172],"immunohistochemistry.":[174],"Cases":[175],"that":[176],"displayed":[177],"negative":[178],"staining":[179],"significantly":[181],"younger.":[182],"correlated":[187],"intratumoral":[189],"Conclusion:":[193],"region":[200,215],"is":[201],"frequent":[202],"GBMs.":[205],"The":[206],"association":[207],"suggests":[216],"crucial":[218],"role":[219],"genes":[222],"immunosurveillance.":[224],"Clin":[225],"Cancer":[226],"Res;":[227],"19(7);":[228],"1816\u201326.":[229],"\u00a92013":[230],"AACR.":[231]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}